Lilly duloxetine drug trial–19 Quit after a suicide – Philadelphia Inquirer

Lilly duloxetine drug trial–19 Quit after a suicide – Philadelphia Inquirer Fri, 13 Feb 2004 19-year old Teri Johnson’s suicide occurred one week after an FDA advisory committee had urged the FDA to issue warnings about prescribing antidepressant drugs for children under 18 because of an increased risk in suicide….

Just Say No – Forbes

Just Say No – Forbes Tue, 16 Nov 2004 When Mrs. Nancy Reagan coined the phrase, Just Say No, she was referring to illicit drug pushers. The current Forbes cover story–Just Say No–refers to the prescription drug industry. "In a perverse kind of symbiosis, the cascade of disease and medical…

Pharma Efforts to Bar Placebo Responders from Trials – WSJ

Pharma Efforts to Bar Placebo Responders from Trials – WSJ Fri, 25 Jun 2004 A clinical trial report in The Lancet debunks the value of Aricept, a popular drug prescribed for Alzheimer’s patients. The findings of a three-year placebo controlled trial show that: “Although the patients taking the drug did…

Failed Experiments: Child-Rearing Experts– Visions and Revisions

Failed Experiments: Child-Rearing Experts– Visions and Revisions Sun, 6 Apr 2003 A new book by Ann Hulbert, “Raising America: Experts, Parents and a Century of Advice About Children,” examines the theories and the validity of “expert” advice that had been dished out as Gospel to American parents. More than other…

Lead author of JAMA article rethinks positive Zoloft report – Guardian

Lead author of JAMA article rethinks positive Zoloft report – Guardian Wed, 1 Oct 2003 In August 2003, the Sertraline Pediatric Study Group reported: “Sertraline-treated patients experienced statistically significantly greater improvement than placebo.” Their report was published in the authoritative Journal of the American Medical Association (JAMA). The authors claimed…

Australian Judge blames Paxil & Effexor: mom free of murder attempt / UK MP

Australian Judge blames Paxil & Effexor: mom free of murder attempt / UK MP Wed, 26 May 2004 Top FDA officials are foot dragging–can’t make up their minds whether protecting children’s lives is a priority. These officials are loath to curtail the dispensing of antidepressants–inasmuch as it would hurt drug…

Bioethics Debate: Ethics of U Penn surgical “drug implant” experiment

Bioethics Debate: Ethics of U Penn Surgical “Drug Implant” Experiment This debate between AHRP President, Vera Sharav and Bioethicist, Paul Root Volpe, Ph.D., University of Pennsylvania, was prompted by an October 7 infomail. The reasons for AHRP’s opposition to drug implants for psychiatric patients are explained here: https://ahrp.org/ahrpspeaks/drugimplant1103.php —–Original Message—–…

How to Quit the Cure–Antidepressant Withdrawal – NewsWeek

How to Quit the Cure–Antidepressant Withdrawal – NewsWeek Wed Aug 3, 2005 The current issue of NEWSWEEK lets readers in on the dirty little secret about the prescribed antidepressants of the SSRI variety. Although psychiatrists shudder at calling a spade a spade, these prescribed drugs are physically addictive–as is evident…

Penn Psychiatrist Files Whistleblower Lawsuit – Investigtion Confirms Medicare Chief Lied

Philadelphia Daily News Pharma Influence: Penn Psychiatrist Files Whistleblower Lawsuit – Investigtion Confirms Medicare Chief Lied to Congress Wed, 7 Jul 2004 “Drug companies not only write checks to hospitals, they write checks to politicians…They write checks to both sides of the aisle.” Two separate news reports provide a glimpse…

Children and antidepressants – CNN Financial Today

Children and antidepressants – CNN Financial Today Fri, 12 Nov 2004 When CNN was looking for an expert with a responsible, balanced view about the concerns of prescribing psychotropic drugs for children, they turned to AHRP. We recommended psychiatrist, Dr. Joseph Glenmullen, a practicing clinician and Harvard faculty member, whose…

FDA Bad Faith – Daniel Troy’s pre-emption defense – Nat’l Law Journal

FDA Bad Faith – Daniel Troy’s pre-emption defense – Nat’l Law Journal Fri, 26 Mar 2004 Federal regulations require drug label warnings if there is “reasonable evidence” of a link between adverse effects and drug action. An article in the National Law Journal shows how s FDA’s chief counsel, Daniel…